Clinical development, meet agentic AI.
We're building toward a future where startup, enrollment, and conduct are measured in days and months, not years — and for the first time, the technology exists to make it real. One platform. Unified workflows, data, and clinical context. Get the full power of agentic AI across the full trial lifecycle at your fingertips
Unlock the agentic advantage
Unify your clinical systems and workflows, and let agentic AI run the complexity giving your teams the leverage to operate at a scale like never before.
Medable’s Agent Platform is purpose-built for clinical development, with deep context across GxP compliance, regulatory requirements, and the operational complexity that general-purpose AI platforms aren't designed to navigate.
.gif)
Less risk. More control. eCOA, reimagined.
Medable's agentified eCOA brings AI-powered workflows to every stage of the trial — from build and deployment to study conduct and data review — delivering consistent, high-quality data and stronger participant adherence.
Spanning eConsent, sensors, provisioned devices, and BYOD, Medable offers a unified experience that reduces operational complexity across every touchpoint of the trial.
Clinical outcomes backed by real-world evidence
Near-perfect compliance across a 70+ site master protocol.
timelines
Half the time to go-live with AI-powered translation.
From weeks to one business day with Medable Studio.
FPI achieved ahead of schedule across a complex regional rollout.
Trusted, traceable, science-ready AI.
Autonomous where it can be, human-led where it must be. Clinical judgment, amplified — never replaced.
- Always traceable: Every automated action logged, explainable, and auditable end-to-end
- Human-In-The-Loop: Critical decisions stay with your team giving you full control
- Innately Compliant: Regulatory context built in from day one — not retrofitted after
Built for Global Regulatory Compliance and Data Integrity
%20GCP.png)
The 1:1:1 Vision
1 day study start.
It's an ambitious benchmark and one Medable is actively building toward. With agentic AI purpose-built for clinical development, we're making meaningful progress toward timelines the industry once thought were out of reach.
1 day patient enrollment.
1 year study conduct
The 1:1:1 vision
1 day study start, 1 day patient enrollment, 1 year study conduct.
It's an ambitious benchmark and one Medable is actively building toward. With agentic AI purpose-built for clinical development, we're making meaningful progress toward timelines the industry once thought were out of reach.
What clients are saying
Medable hired a third-party firm to get real feedback from customers across our trials. Here’s what they had to say about us.
Better compliance and faster study startup
A top-10 pharmaceutical company saw “increasing per-protocol data collection compliance” and “significantly reduced participant recruitment time.”
Increased oversight and scalability with eCOA and eConsent
A pharmaceutical group found success in “increased scalability, simplified clinical trial experience, and better oversight.”
Greater insights paired with an easy to use system
A top-10 pharmaceutical company achieved “streamlined user experience, aggregated data for greater insights, and seamless integration into participants lives.”
[Agent Platform] gives us a holistic view, but what really matters is the site. Normally, we find out about enrollments or screen failures through hundreds of emails, easy to miss. Having that site-specific data right when we log in is a real game changer.
The latest news
Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
TMF Agent significantly improves quality and consistency while drastically reducing the manual effort in document management. It is built on Medable’s Agent Studio, the industry’s first agentic AI platform for clinical development.
Medable Named a Leader Amid Growing eCOA Adoption
Everest Group’s 2025 Life Sciences eCOA PEAK Matrix® Assessment highlights Medable eCOA leadership in ease of use, AI innovation, and patient-centered design
.webp)
Medable Launches The Industry’s First Agentic AI Platform and CRA Agent; Removes Bottlenecks in Clinical Development
Agent Studio marks a turning point in clinical research, moving from human-heavy processes to scalable agents that streamline work and accelerate trials
